ライフサイエンスコーパス: cognitive behavior therapy

1 ts in delusions and hallucinations following cognitive behavior therapy.

2 ome in the treatment of bulimia nervosa with cognitive behavior therapy.

3 mpared treatment outcomes for imipramine and cognitive behavior therapy.

4 p profile were relatively less responsive to cognitive behavior therapy.

5 average of 3 weeks with intensive individual cognitive behavior therapy.

6 d implementation of the skills emphasized in cognitive behavior therapy.

7 mission to escitalopram and poor response to cognitive behavior therapy.

8 treatment with combination escitalopram and cognitive behavior therapy.

9 (10-20 mg/d) or 16 sessions of manual-based cognitive behavior therapy.

10 or (2) switch to a different medication plus cognitive behavior therapy.

11 another SSRI or venlafaxine, with or without cognitive behavior therapy.

12 interpersonal and social rhythm therapy, and cognitive behavior therapy.

13 ciated with poor response to medications and cognitive behavior therapy.

14 fessional that included multiple elements of cognitive behavior therapy.

15 n, and 2) guided self-help, an adaptation of cognitive behavior therapy.

16 ered most strongly to the ideal prototype of cognitive behavior therapy.

17 ded in the primary analysis: 12 remitters to cognitive behavior therapy, 11 remitters to escitalopram

18 nths), motivational enhancement therapy plus cognitive behavior therapy (12 sessions over 6 months),

19 returned for a second testing session after cognitive behavior therapy; 13 comparison children parti

20 ng out combined) was significantly lower for cognitive behavior therapy (22%) than for nutritional co

21 The dropout rate was similar to regular cognitive behavior therapy (30%) and unrelated to treatm

22 significantly more of the patients receiving cognitive behavior therapy (44%) than nutritional counse

23 nd at a higher rate than the group receiving cognitive behavior therapy (53% versus 22%).

24 hs in a higher proportion of patients in the cognitive behavior therapy (71%) and supportive stress-m

25 third of those who completed self-management cognitive behavior therapy achieved high-end state funct

26 A course of cognitive behavior therapy, added to the antipsychotic r

27 an augmentation strategy for exposure-based cognitive behavior therapy and (2) conducted in humans d

28 icipated in the follow-up study: 25 received cognitive behavior therapy and 28 received relaxation th

29 A total of 68% of the patients who received cognitive behavior therapy and 36% who received relaxati

30 e behavior therapy, and treatments combining cognitive behavior therapy and contingency management.

31 Cognitive behavior therapy and graded exercise can be ef

32 The relation between response to cognitive behavior therapy and HPA activity was not expl

33 CALM (cognitive behavior therapy and pharmacotherapy medicatio

34 CALM (cognitive behavior therapy and pharmacotherapy recommend

35 brain mean) was associated with remission to cognitive behavior therapy and poor response to escitalo

36 Both cognitive behavior therapy and supportive stress managem

37 nt appears promising, as is a combination of cognitive-behavior therapy and morning bright light.

38 emitters to escitalopram, 9 nonresponders to cognitive behavior therapy, and 6 nonresponders to escit

39 e integrated with motivational interviewing, cognitive behavior therapy, and family intervention over

40 e integrated with motivational interviewing, cognitive behavior therapy, and family or caregiver inte

41 ency management, relapse prevention, general cognitive behavior therapy, and treatments combining cog

42 elf-help, a psychological treatment based on cognitive behavior therapy, appears ineffective, but tre

43 treatment for panic disorder, exposure-based cognitive behavior therapy, are reviewed, and their appl

44 believe is the first empirical evaluation of cognitive behavior therapy as a posthospitalization trea

45 This study aimed to evaluate whether blended cognitive behavior therapy (bCBT) can reduce the severit

46 cation to cognitive behavior therapy favored cognitive behavior therapy, but tests comparing the two

47 Serotonin reuptake inhibitors (SRIs) and cognitive behavior therapy by exposure and ritual preven

48 Cognitive behavior therapy (CBT) among youth with obsess

49 in a randomized controlled trial comparing a cognitive behavior therapy (CBT) and pharmacotherapy int

50 Cognitive behavior therapy (CBT) can be effective for la

51 he clinical effectiveness of protocol-driven cognitive behavior therapy (CBT) for insomnia, delivered

52 and cost-effectiveness of family therapy and cognitive behavior therapy (CBT) guided self-care in ado

53 Cognitive behavior therapy (CBT) has been established as

54 Cognitive behavior therapy (CBT) has been identified as

55 Grief-focused cognitive behavior therapy (CBT) has been shown to be ef

56 at augmentation with short-term OCD-specific cognitive behavior therapy (CBT) may provide additional

57 iveness of fluoxetine hydrochloride therapy, cognitive behavior therapy (CBT), and their combination

58 ns are shown for family therapy, followed by cognitive behavior therapy (CBT), motivational enhanceme

59 onin reuptake inhibitor (SSRI) sertraline or cognitive behavior therapy (CBT), participants completed

60 unmedicated depressed individuals respond to cognitive behavior therapy (CBT).

61 of interpersonal and social rhythm therapy, cognitive behavior therapy [CBT], or family-focused ther

62 reatment (BWL) and guided self-help based on cognitive behavior therapy (CBTgsh) have both resulted i

63 Cognitive behavior therapy compared with EUC significant

64 3 months of treatment, participants in both cognitive behavior therapy conditions had significant re

65 utcomes in the antidepressant medication and cognitive behavior therapy conditions of the Treatment o

66 er receive forms of psychotherapy other than cognitive behavior therapy, even though there is little

67 sizes comparing antidepressant medication to cognitive behavior therapy favored cognitive behavior th

68 domization to either escitalopram oxalate or cognitive behavior therapy for 12 weeks.

69 (DCS) augments the effects of exposure-based cognitive behavior therapy for anxiety, obsessive-compul

70 rior to placebo in augmenting the effects of cognitive behavior therapy for anxiety, obsessive-compul

71 es patients who will and will not respond to cognitive behavior therapy for bulimia nervosa, potentia

72 Cognitive behavior therapy for chronic fatigue syndrome

73 Although cognitive behavior therapy for insomnia (CBT-I) has been

74 This study reports on an open-label trial of cognitive behavior therapy for insomnia and disturbing d

75 Components of cognitive behavior therapy for insomnia, especially stim

76 Five aspects of cognitive behavior therapy for schizophrenia are address

77 offer a broad perspective on the subject of cognitive behavior therapy for schizophrenia for the Ame

78 The strength of the evidence supporting cognitive behavior therapy for schizophrenia suggests th

79 rent practice and data supporting the use of cognitive behavior therapy for schizophrenia.

80 sis of empirical evidence, to be superior to cognitive behavior therapy for the acute treatment of se

81 growing body of evidence supports the use of cognitive behavior therapy for the treatment of schizoph

82 in the motivational enhancement therapy plus cognitive behavior therapy group and -0.19% (CI, -0.53%

83 oportions were employed, but patients in the cognitive behavior therapy group worked significantly mo

84 Cognitive behavior therapy had greater and more durable

85 Cognitive behavior therapy has fared as well as antidepr

86 rapy (CT), often labeled as the generic term cognitive behavior therapy, has been shown to be effecti

87 Parents' views of the credibility of cognitive behavior therapy improved compared with parent

88 ere treated with 18 sessions of manual-based cognitive behavior therapy in a three-site study.

89 on of the efficacy of any psychotherapy, and cognitive behavior therapy in particular, in posthospita

90 BDNF Val66Met genotype predicts response to cognitive behavior therapy in PTSD and is in accord with

91 e to psychotherapy, we examined responses to cognitive behavior therapy in relation to electroencepha

92 e authors therefore investigated response to cognitive behavior therapy in relation to pretreatment m

93 te outcomes of antidepressant medication and cognitive behavior therapy in the severely depressed out

94 Significantly more patients receiving cognitive behavior therapy, in relation to those in rela

95 Guided self-help based on cognitive behavior therapy is a first-line treatment opt

96 livered motivational enhancement therapy and cognitive behavior therapy is feasible for adults with p

97 Cognitive behavior therapy is more efficacious than SBFT

98 nitive therapy (often labeled generically as cognitive behavior therapy) is efficacious either alone

99 In the completer group, self-management cognitive behavior therapy led to greater reductions in

100 n the intent-to-treat group, self-management cognitive behavior therapy led to sharper declines in da

101 Self-management cognitive behavior therapy may be a way of delivering ef

102 Cognitive behavior therapy may benefit the large number

103 e-adjusted Hamilton scores were lower in the cognitive behavior therapy (mean [standard error], 5.5 [

104 hree randomized, controlled trials comparing cognitive behavior therapy, medication, and their combin

105 Cognitive behavior therapy (n = 70) conducted in the pri

106 ar were randomly assigned to self-management cognitive behavior therapy (N=24) or supportive counseli

107 with recommended standard treatment (either cognitive behavior therapy [N=36] or imipramine [N=22]).

108 erapy intervention (8 weeks of manual-guided cognitive behavior therapy) (n = 90), or referral to com

109 of panic disorder than treatment with either cognitive behavior therapy or imipramine; results obtain

110 d to, or had relapsed following, a course of cognitive behavior therapy or interpersonal psychotherap

111 er and were treated for 16 weeks with either cognitive behavior therapy or interpersonal psychotherap

112 re randomly assigned to 1 year of outpatient cognitive behavior therapy or nutritional counseling.

113 andomly assigned to receive the two kinds of cognitive behavior therapy or received standard communit

114 Twelve weeks of cognitive behavior therapy or supportive stress manageme

115 permit distinction of the additive effect of cognitive behavior therapy plus motivational enhancement

116 Combined psychotherapy (8 sessions of cognitive behavior therapy) plus pharmacotherapy (citalo

117 with PTSD underwent an 8-week exposure-based cognitive behavior therapy program and provided mouth sw

118 In addition, adherence to the cognitive behavior therapy prototype yielded more positi

119 raining programs were complying with the new cognitive behavior therapy requirement.

120 he association between sleep abnormality and cognitive behavior therapy response was not significant

121 Cognitive behavior therapy resulted in more rapid relief

122 Both the interpersonal psychotherapy and cognitive behavior therapy sessions adhered most strongl

123 anscripts of interpersonal psychotherapy and cognitive behavior therapy sessions conducted as part of

124 Cognitive behavior therapy showed a lower rate of MDD at

125 Both groups receiving cognitive behavior therapy sustained greater improvement

126 ly assigned to 1 of 3 treatments: individual cognitive behavior therapy, systemic behavior family the

127 was to compare the efficacy of a manualized cognitive behavior therapy that addresses both posttraum

128 nce abuse (seeking safety) with a manualized cognitive behavior therapy that addresses only substance

129 before and after 16 weeks of treatment with cognitive behavior therapy to determine the stability or

130 or combined treatment is for the addition of cognitive behavior therapy to pharmacotherapy for patien

131 or most patients with BED, with IPT (or full cognitive behavior therapy) used for patients with low s

132 ens of brief interpersonal psychotherapy and cognitive behavior therapy using the Psychotherapy Proce

133 st-assisted, Internet-based, self-management cognitive behavior therapy versus Internet-based support

134 his study evaluated the long-term outcome of cognitive behavior therapy versus relaxation therapy for

135 icipated in a randomized controlled trial of cognitive behavior therapy versus relaxation therapy for

136 Cognitive behavior therapy was initiated at a median of

137 Response to inpatient cognitive behavior therapy was inversely associated with

138 Cognitive behavior therapy was markedly underused.

139 Cognitive behavior therapy was positively evaluated and

140 Cognitive behavior therapy was significantly more effect

141 Cognitive behavior therapy was superior to usual care at

142 Outcomes of antidepressant medication and cognitive behavior therapy were compared within each of

143 lysis of variance treatment (escitalopram or cognitive behavior therapy) x outcome (remission or nonr